Lymphedema After Urologic Surgery

Sponsor
Vastra Gotaland Region (Other)
Overall Status
Recruiting
CT.gov ID
NCT05264337
Collaborator
(none)
400
1
93.6
4.3

Study Details

Study Description

Brief Summary

Lymphedema of the extremities is common after lymph node surgery in treating several forms of cancer, e.g., breast cancer. However, very little is known of the occurrence of lymphedema of the lower extremities after urologic surgery with lymph node dissection. This project aims to describe the frequency and grade of lymphedema arising after urologic surgery, using the Lymphedema Quality of Life Questionnaire (LymQOL), Delfin MoistureMeter D, and lower limb volume measurements.

Condition or Disease Intervention/Treatment Phase
  • Other: Self-reported lymphedema
  • Other: Dielectric constant ratio
  • Other: Limb volume

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Lymphedema in the Lower Extremities After Urologic Surgery With Lymph Node Dissection
Actual Study Start Date :
Mar 14, 2022
Anticipated Primary Completion Date :
Jan 1, 2027
Anticipated Study Completion Date :
Jan 1, 2030

Arms and Interventions

Arm Intervention/Treatment
Radical Cystectomy

Patients undergoing radical cystectomy with pelvic lymph node dissection for urinary bladder cancer

Other: Self-reported lymphedema
Lymphedema as reported by LymQOL questionnaire.

Other: Dielectric constant ratio
Measurement of percentage tissue water content of lower extremities by dielectric constant ratio measured by MoistureMeter D.

Other: Limb volume
Measurement of lymphedema by limb volume of lower extremities by multiple measurements of circumference.

Radical Prostatectomy

Patients undergoing radical prostatectomy with pelvic lymph node dissection for prostate cancer

Other: Self-reported lymphedema
Lymphedema as reported by LymQOL questionnaire.

Retroperitoneal

Patients undergoing retroperitoneal lymph node dissection for testicular cancer

Other: Self-reported lymphedema
Lymphedema as reported by LymQOL questionnaire.

Other

Patients undergoing other urologic surgery with lymph node dissection of inguinal, iliacal or retroperitoneal lymph nodes

Other: Self-reported lymphedema
Lymphedema as reported by LymQOL questionnaire.

Outcome Measures

Primary Outcome Measures

  1. Number of patients with self-reported lymphedema at 12 months [12 months after surgery]

    Frequency and grade of self-reported swelling of the lower extremities as graded by LymQOL questionnaire

  2. Number of patients with self-reported lymphedema at 24 months [24 months after surgery]

    Frequency and grade of self-reported swelling of the lower extremities as graded by LymQOL questionnaire

  3. Change in tissue water content measured by MoistureMeterD Compact at 12 months [12 months after surgery]

    Percent tissue water content calculated from the dielectric constant as measured by MoistureMeterD Compact

  4. Change in tissue water content measured by MoistureMeterD Compact at 24 months [24 months after surgery]

    Percent tissue water content calculated from the dielectric constant as measured by MoistureMeterD Compact

  5. Change in lower limb volume calculated by measuring the circumference of the lower extremities at 12 months [12 months after surgery]

  6. Change in lower limb volume calculated by measuring the circumference of the lower extremities at 24 months [24 months after surgery]

Secondary Outcome Measures

  1. Number of patients with self-reported lymphedema at 1 month [1 month after surgery]

    Frequency and grade of self-reported swelling of the lower extremities as graded by LymQOL questionnaire

  2. Number of patients with self-reported lymphedema at 3 months [3 months after surgery]

    Frequency and grade of self-reported swelling of the lower extremities as graded by LymQOL questionnaire

  3. Number of patients with self-reported lymphedema at 6 months [6 months after surgery]

    Frequency and grade of self-reported swelling of the lower extremities as graded by LymQOL questionnaire

  4. Change in tissue water content measured by MoistureMeterD Compact at 1 month [1 month after surgery]

    Percent tissue water content calculated from the dielectric constant as measured by MoistureMeterD Compact

  5. Change in tissue water content measured by MoistureMeterD Compact at 3 months [3 months after surgery]

    Percent tissue water content calculated from the dielectric constant as measured by MoistureMeterD Compact

  6. Change in tissue water content measured by MoistureMeterD Compact at 6 months [6 months after surgery]

    Percent tissue water content calculated from the dielectric constant as measured by MoistureMeterD Compact

  7. Change in lower limb volume calculated by measuring the circumference of the lower extremities at 1 month [1 month after surgery]

    Measurements of circumference every 6 cm along the lower limbs.

  8. Change in lower limb volume calculated by measuring the circumference of the lower extremities at 3 month [3 month after surgery]

    Measurements of circumference every 6 cm along the lower limbs.

  9. Change in lower limb volume calculated by measuring the circumference of the lower extremities at 6 month [6 month after surgery]

    Measurements of circumference every 6 cm along the lower limbs.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing urologic surgery with lymph node dissection
Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sahlgrenska University Hospital Göteborg Sweden 41345

Sponsors and Collaborators

  • Vastra Gotaland Region

Investigators

  • Principal Investigator: Henrik Kjölhede, MD, PhD, Sahlgrenska University Hospital, Gothenburg University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vastra Gotaland Region
ClinicalTrials.gov Identifier:
NCT05264337
Other Study ID Numbers:
  • 2021-04840
First Posted:
Mar 3, 2022
Last Update Posted:
Mar 31, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Vastra Gotaland Region
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2022